| 18/05 | Lysogene S.A. Provides Clinical Update on AAvance Phase 2/3 Clinical Trial with Gene Th.. |  |
| 28/04 | LYSOGENE : Quarterly financial reporting / First quarter financial report | |
| 21/04 | Lysogene's Gene Therapy Shows Long-Term Rescue of Fragile X Syndrome in Mouse Model | |
| 21/04 | LYSOGENE : Inside Information / Other news releases | |
| 20/04 | LYSOGENE : Terms of availability of a registration document or its updates | |
| 31/03 | Lysogene S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 24/02 | Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2/3 Cli.. | |
| 11/02 | Lysogene Reports Additional Positive Biomarker Data With LYS-SAF302 and Favorable Safet.. | |
| 07/02 | Lysogene Jumps 14% On New Chief Medical Officer's Appointment | |
| 07/02 | Lysogene Doses First Patient in Early-Stage Rare Disease Study in France; Shares Up 7% | |
| 07/02 | Lysogene S.A. Provides Medical Update | |
| 27/01 | LYSOGENE : Inside Information / Information on annual revenues | |
| 13/01 | Lysogene Restores Global Commercial Rights of Rare Disease Treatment | |
| 13/01 | Lysogene Announces Termination of License Agreement With Sarepta for LYS-SAF302 Program.. | |
| 2021 | European stocks close lower in thin holiday trade | |
| 2021 | EN DIRECTO DESDE LOS MERCADOS : ACS, Airbus, Acerinox, Banco de Sabadell, HSBC, Icade, Cos.. |  |
| 2021 | Sesión reducida antes de Navidad | |
| 2021 | Lysogene S.A. announced that it expects to receive €15 million in funding from Eur.. | |
| 2021 | Lysogene Awards Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program | |
| 2021 | Lysogene S.A. Secures EUR 4.3 Million Non-Dilutive Financing from Bpifrance to Support .. | |
| 2021 | Lysogene S.A. announced that it has received ?4.3 million in funding from Bpifrance Inv.. | |
| 2021 | Lysogene S.A. Reports Earnings Results for the First Half 2021 | |
| 2021 | GLOBAL MARKETS LIVE : Sanofi, Walt Disney, Roche, Flatexdegiro, KBC Group... | |
| 2021 | LYSOGENE : Announces First Patient in the United States Dosed with LYS-GM101 Investigation.. | |
| 2021 | LYSOGENE : Doses First Patient with Investigational Gene Therapy in US to Treat Genetic Di.. | |
| 2021 | Lysogene Announces First Patient in the United States Dosed with LYS-GM101 Investigatio.. | |
| 2021 | Lysogene Enters into an Exclusive Worldwide License Agreement with SATT Conectus for a .. | |
| 2021 | GLOBAL MARKETS LIVE : Tesla, BT Group, GameStop, Alibaba, Boeing... | |
| 2021 | Vuelve el cóctel de bancos centrales e inflación | |
| 2021 | | |
| 2021 | Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for .. | |
| 2021 | LYSOGENE : Meeting Notice of the Annual Ordinary and Extraordinary General Meeting to be h.. | |
| 2021 | Lysogene Announces Phase 3 Gene Therapy Platform Company Targeting Central Nervous Syst.. | |
| 2021 | EN DIRECTO DESDE LOS MERCADOS : Nokia, Apple, Facebook, Logitech, Total, STMicro, Airbus, .. | |
| 2021 | LYSOGENE : 2020 annual report of liquidity contract | |
| 2021 | Lysogene S.A. Reports Earnings Results for the Year Ended 31 December 2020 | |
| 2021 | LYSOGENE : Reports its Cash Position as of 31 December 2020 | |
| 2021 | LYSOGENE : Reports LYS-SAF302 Biomarker Data Presented at the WORLDSymposium™ 2021 | |
| 2021 | Lysogene Reports LYS-SAF302 Biomarker Data Presented at the WORLDSymposium 2021 | |
| 2021 | LYSOGENE : Up 13% After Getting Trial Clearance From US FDA For Gene Therapy | |
| 2021 | LYSOGENE : Receives FDA Clearance of Investigational New Drug Application to Initiate the .. | |
| 2021 | Lysogene S.A. Receives FDA Clearance of Investigational New Drug Application to Initiat.. | |
| 2021 | LYSOGENE : Gets $6.1 Million In Financing From France's BRED | |
| 2021 | LYSOGENE : Secures €5 million in Non-Dilutive Financing | |
| 2021 | Lysogene Secures €5 Million in Non-Dilutive Financing | |
| 2021 | LYSOGENE : Announces Its Financial Calendar For 2021 | |
| 2021 | LYSOGENE : Half-Year Report on the Liquidity Contract Signed by Lysogene with Kepler Cheuv.. | |
| 2021 | LYSOGENE : Up 8% After Receiving Approval For Clinical Trial in UK | |
| 2021 | LYSOGENE : Receives MHRA and Research Ethics Committee Approvals to Initiate the Gene Ther.. | |
| 2021 | Lysogene Receives MHRA and Research Ethics Committee Approvals to Initiate the Gene The.. | |
| 2020 | LYSOGENE : Releases Positive Biomarker Data for LYS-SAF302 in Central Nervous System Disor.. | |
| 2020 | LYSOGENE : Reports Positive Biomarker Data With LYS-SAF302 | |
| 2020 | Lysogene Reports Positive Biomarker Data With LYS-SAF302 | |
| 2020 | LYSOGENE : Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene.. | |
| 2020 | LYSOGENE : Reports its Cash Position as of 30 September 2020 | |
| 2020 | LYSOGENE : provides update on the AAVance Clinical Trial Evaluating LYS-SAF302 in Patients.. | |
| 2020 | LYSOGENE : Provides Update on the AAVance Clinical Trial Evaluating LYS-SAF302 in Patients.. | |
| 2020 | Lysogene Provides Update on the AAVance Clinical Trial Evaluating Lys-Saf302 in Patient.. | |
| 2020 | LYSOGENE : Reports First Half 2020 Financial Results and Provides Operational Update | |
| 2020 | Lysogene Reports Earnings Results for the First Half Ended June 30, 2020 | |
| 2020 | LYSOGENE : Reports First Half 2020 Financial Results and Provides Operational Update | |
| 2020 | LYSOGENE : First Half 2020 Business Update | |
| 2020 | LYSOGENE : Announces a Research Collaboration With the Weizmann Institute of Science | |
| 2020 | Lysogene Announces a Research Collaboration with the Yeda Research and Development Co L.. | |
| 2020 | LYSOGENE : Releases the Results From June 26, 2020 Ordinary Annual and Extraordinary Gener.. | |
| 2020 | LYSOGENE : announces important updates on AAVance phase 2/3 clinical trial with LYS-SAF302.. | |
| 2020 | Lysogene Announces Important Updates on AAVance Phase 2/3 Clinical Trial with LYS-SAF30.. | |
| 2020 | LYSOGENE : NOVASEP and LYSOGENE Announce their New Collaboration for Development and Produ.. | |
| 2020 | Novasep and Lysogene Announce Their New Collaboration for Development and Production of.. | |
| 2020 | LYSOGENE : Annual Ordinary and Extraordinary General Meeting of 26 June 2020 | |
| 2020 | LYSOGENE : Announces Presentations at Upcoming Meetings | |
| 2020 | LYSOGENE : Kepler Cheuvreux Initiates Coverage of Lysogene | |
| 2020 | LYSOGENE : Announces Filing of 2019 Universal Registration Document | |
| 2020 | LYSOGENE : Reports Its Cash Position as of 31 March 2020 | |
| 2020 | Lysogene S.A. Reports Consolidated Earnings Results for the Year Ended 31 December 2019 | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
